Sell CODX by Nov 24, 2026.

Per a post on **Aug 20**, CODX is a very good company working on many projects (including an Ebola assay). They recently filed a **501(k) with the FDA for a Flu A/B and RSV PCR test (planning to add COVID-19 later)**, which will allow clinics and pharmacies to give results in about 30 minutes and not send the test to a lab to get results. On **Aug 24**, CODX filed an S-3 registering over 3.4M shares for resale by selling …